Cite
Baicalein resensitizes tamoxifen‐resistant breast cancer cells by reducing aerobic glycolysis and reversing mitochondrial dysfunction via inhibition of hypoxia‐inducible factor‐1α.
MLA
Chen, Yan, et al. “Baicalein Resensitizes Tamoxifen‐resistant Breast Cancer Cells by Reducing Aerobic Glycolysis and Reversing Mitochondrial Dysfunction via Inhibition of Hypoxia‐inducible Factor‐1α.” Clinical & Translational Medicine, vol. 11, no. 11, Nov. 2021, pp. 1–24. EBSCOhost, https://doi.org/10.1002/ctm2.577.
APA
Chen, Y., Zhang, J., Zhang, M., Song, Y., Zhang, Y., Fan, S., Ren, S., Fu, L., Zhang, N., Hui, H., & Shen, X. (2021). Baicalein resensitizes tamoxifen‐resistant breast cancer cells by reducing aerobic glycolysis and reversing mitochondrial dysfunction via inhibition of hypoxia‐inducible factor‐1α. Clinical & Translational Medicine, 11(11), 1–24. https://doi.org/10.1002/ctm2.577
Chicago
Chen, Yan, Jingyu Zhang, Minqin Zhang, Yuxuan Song, Yue Zhang, Shuangqin Fan, Shuang Ren, et al. 2021. “Baicalein Resensitizes Tamoxifen‐resistant Breast Cancer Cells by Reducing Aerobic Glycolysis and Reversing Mitochondrial Dysfunction via Inhibition of Hypoxia‐inducible Factor‐1α.” Clinical & Translational Medicine 11 (11): 1–24. doi:10.1002/ctm2.577.